[BostonCard]

Not interested in the prediction  game. Good news in Ca.  Deaths hit low last week.  And the dire prediction on hospitization rates soaring in October did not come to pass.


Course, no one wants to hear good news on this board. Not at least till Biden wins. Which I find interesting - cause I doubt there is one person that reads (or at least posts) on this site that will be voting for Trump. .

Here's some good news:

https://www.fiercebiotech.com/biotech/re...-2-3-trial

Regeneron’s anti-SARS-CoV-2 antibody cocktail has significantly reduced medical visits in ambulatory COVID-19 patients. The phase 2/3 clinical trial linked REGN-COV2 to a 57% decline in medical visits associated with COVID-19 in the 29 days after treatment.

The downside is that this is an IV antibody cocktail, but you could imagine a case where high risk patients who have been exposed get the cocktail as prophylaxis.  Cutting the hospitalization rate by over half is real progress.

BC

[BostonCard]

Not interested in the prediction  game. Good news in Ca.  Deaths hit low last week.  And the dire prediction on hospitization rates soaring in October did not come to pass.


Course, no one wants to hear good news on this board. Not at least till Biden wins. Which I find interesting - cause I doubt there is one person that reads (or at least posts) on this site that will be voting for Trump. .

Here's some good news:

https://www.fiercebiotech.com/biotech/re...-2-3-trial

Regeneron’s anti-SARS-CoV-2 antibody cocktail has significantly reduced medical visits in ambulatory COVID-19 patients. The phase 2/3 clinical trial linked REGN-COV2 to a 57% decline in medical visits associated with COVID-19 in the 29 days after treatment.

The downside is that this is an IV antibody cocktail, but you could imagine a case where high risk patients who have been exposed get the cocktail as prophylaxis.  Cutting the hospitalization rate by over half is real progress.

BC